Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providers
Interventional Cardiology Physician in Santa Ana, CA
NPI: 1114924727Primary Practice Location
Cardiology Consultants of OC Medical Group Inc.
801 N Tustin Ave, Santa Ana, CA
Primary Employer
Cardiology Consultants of OC Medical Group Inc.
cardiologyspecialistsoc.com
HQ Phone
Get M.D. Harinder's Phone Numberphone_androidMobile
Get M.D. Harinder's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
1991 - 2027
American Board of Internal Medicine
Cardiovascular Disease
University of Southern California/LAC+USC Medical Center
Fellowship • Cardiovascular Disease
1994 - 1997
University of Southern California/Los Angeles General Medical Center (USC/LA General)
Residency • Internal Medicine
1991 - 1993
Zucker School of Medicine at Hofstra/Northwell
Internship • Internal Medicine
1990 - 1991
Dayanand Medical College
Medical School
Until 1989
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 93010Routine electrocardiogram (EKG) using at least 12 leads with interpretation and report | 775 | 996 |
| 2 | 93306Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | 756 | 789 |
| 3 | 99213Established patient office or other outpatient visit, typically 15 minutes | 492 | 1,371 |
| 4 | 93000Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 379 | 470 |
| 5 | 99222Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 291 | 320 |
Edoxaban vs warfarin in patients with nonvalvular atrial fibrillation in the US Food and Drug Administration approval population: An analysis from the Effective Antico...
Authors: Alon Eisen, Robert P. Giugliano, Christian T. Ruff, Francesco Nordio, Harinder S. Gogia
Authors: Elkayam, U, Cohen, G, Gogia, H, Mehra, A, Johnson, J V, Chandraratna, P A
Journal: J Am Coll Cardiol
Initiating sacubitril/valsartan (LCZ696) in heart failure: results of TITRATION, a double‐blind, randomized comparison of two uptitration regimens
Authors: Michele Senni, John J.V. McMurray, Rolf Wachter, Hugh F. McIntyre, Antonio Reyes
Lead Sponsor: Bristol-Myers Squibb
Intervention / Treatment: DRUG: Placebo (Matching with BMS-919373), DRUG: BMS-919373
